Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 4

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

pegylated liposomal doxorubicin / Generic mfg.

NCT00727961: A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)

Completed

Pegylated Liposomal Doxorubicin hydrochloride, Caelyx

Merck Sharp & Dohme LLC

Ovarian Neoplasms

01/08

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites